CMS to apply anti-markup rules for Medicare diagnostic tests
Results for Life campaign shines new light on genetic testing and policy ramifications
—Why education matters
—Range and types of genetic tests
—Use in disease prevention, prediction of risk
—Benefits of personalized medicine, tailoring care to the individuals’ genetic profile
NPI advisory: Use of NPI for out-of-jurisdiction purchased screening mammograms and diagnostic tests
Medicare coverage advisory: Changes in 2009 to the ‘Welcome to Medicare’ preventive physical exam
CLIAC adopts ‘good lab practices’ report for molecular diagnostics and genetic testing
Upcoming G-2 Conferences: LabCompete Sales & Marketing, Dec. 10-12; Business & Financial Strategies for Molecular Diagnostics, Feb. 2-4, 2009

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

November 10, 2008 - Table of Contents

NIR November 10, 2008 (full PDF issue)

Obama Era Promises New Initiatives in Health Care

Medicare Physician Fees to Rise 1.1 Percent in 2009

CMS Finalizes Anti-Markup Rules for Diagnostic Testing

Spotlight on Genetic Testing in Front-Line Health Care

NPI Advisory: Out-of-Jurisdiction Screening Mammograms, Diagnostic Services

Medicare Coverage Advisory: Major Changes Ahead for ‘Welcome to Medicare’ Physical

New Guidance From CLIAC on Good Lab Practices